Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

MariMed Inc. (MRMD) had Revenue of $157.96M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$157.96M
Net Income	$-12.16M
Cost of Goods Sold	$95.10M
Gross Profit	$62.87M
Operating Expenses	$155.05M
Operating Income	$2.91M
Non-Operating Income/Expense	$-6.88M
Pre-Tax Income	$-3.97M
Normalized Pre-Tax Income	$-3.97M
Income after Taxes	$-12.13M
Income from Continuous Operations	$-12.13M
Consolidated Net Income/Loss	$-12.13M
Normalized Income after Taxes	$-12.13M
EBIT	$2.91M
EBITDA	$14.42M
Weighted-Average Shares Outstanding (Basic)	379.15M
Weighted-Average Shares Outstanding (Diluted)	379.15M
Earnings per Share (EPS) (Basic)	$-0.03
Earnings per Share (EPS) (Diluted)	$-0.03
Balance Sheet Financials
Current Assets	$53.51M
Property, Plant, and Equipment	$94.17M
Long-Term Assets	$153.48M
Total Assets	$206.99M
Current Liabilities	$48.68M
Long-Term Debt	$71.79M
Long-Term Liabilities	$98.44M
Total Liabilities	$147.11M
Common Equity	$59.88M
Tangible Shareholders Equity	$25.43M
Shareholders Equity	$59.88M
Common Shares Outstanding	381.48M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.79M
Cash Flow from Investing Activities	$-17.13M
Cash Flow from Financial Activities	$2.98M
Beginning Cash	$14.64M
End Cash	$7.28M
Increase/Decrease in Cash	$-7.36M
Stock-Based Compensation	$1.05M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.55
Debt to Equity Ratio	1.23
Gross Margin	39.80%
Operating Margin	1.84%
EBIT Margin	1.84%
EBITDA Margin	9.13%
Pre-Tax Profit Margin	-2.51%
Profit Margin	-7.70%
Free Cash Flow	$-5.15M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.76
Inventory Turnover	2.84
Receiveable Turnover	16.99
Days Sales in Receivables	21.48
Return on Equity	-20.25%
Return on Tangible Equity	-47.70%
Return on Assets	-5.86%
Return on Investments	-9.21%
Book Value Per Share	$0.16
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$0.02

Data from Zacks Investment Research, Inc.